Treatment with either chloroquine, an inhibitor that blocks the fusion of lysosome and autophagosome, or bortezomib increased p62 and LC3-II in a time-dependent manner in ovarian cancer cells (Figure 3a). This evidence concerns the gene SQSTM1 and ovarian cancer.